Programmed cell death-1 and its ligands: Current knowledge and possibilities in immunotherapy (2023)
Gutic, Bojana; Bozanovic, Tatjana; Mandic, Aljosa; Dugalic, Stefan; Todorovic, Jovana; Stanisavljevic, Dejana; Dugalic, Miroslava Gojnic; Sengul, Demet; Detanac, Dzenana A; Sengul, Ilker; Detanac, Dzemail; Soares Junior, Jose Maria 
Subjects: NEOPLASIAS HEPÁTICAS, CARCINOMA HEPATOCELULAR, CÉLULAS DENDRÍTICAS, IMUNOHISTOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUTIC, Bojana et al. Programmed cell death-1 and its ligands: Current knowledge and possibilities in immunotherapy. Clinics, v. 78, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53969. Acesso em: 03 nov. 2024.APA
Gutic, B., Bozanovic, T., Mandic, A., Dugalic, S., Todorovic, J., Stanisavljevic, D., et al. (2023). Programmed cell death-1 and its ligands: Current knowledge and possibilities in immunotherapy. Clinics, 78. doi:10.1016/j.clinsp.2023.100177NLM
Gutic B, Bozanovic T, Mandic A, Dugalic S, Todorovic J, Stanisavljevic D, Dugalic MG, Sengul D, Detanac DA, Sengul I, Detanac D, Soares Junior JM. Programmed cell death-1 and its ligands: Current knowledge and possibilities in immunotherapy [Internet]. Clinics. 2023 ; 78[citado 2024 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53969Vancouver
Gutic B, Bozanovic T, Mandic A, Dugalic S, Todorovic J, Stanisavljevic D, Dugalic MG, Sengul D, Detanac DA, Sengul I, Detanac D, Soares Junior JM. Programmed cell death-1 and its ligands: Current knowledge and possibilities in immunotherapy [Internet]. Clinics. 2023 ; 78[citado 2024 nov. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53969
